StockMacro
Menu

Mesa Laboratories

$127.93 +20% in 6 monthsMarket cap $719.0M

MLAB on XNAS, Technology, Mesa Laboratories Inc, job postings

Measures activity, not value. Not investment advice.

Shares rose 79% in a year while revenue grew 2.5% to $251.3M over 12 months.

  • GoodInstitutional holders grew 15% to 180 from 156 in one quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Industry
Industrial instruments for measurement, display, and control (Technology)
Employees
717
Website
mesalabs.com
Listed
Nasdaq, US
Last results
9 Nov 2026
Next results
expected around 2 Feb 2027 (an estimate: a year ago it reported on 3 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $62.3M, net income $4.3M.
Quarter to 31 Dec 2021: revenue $54.7M, net income -$2.1MQuarter to 31 Dec 2021: revenue $54.7M, net income -$2.1MQuarter to 31 Mar 2022: revenue $58.9M, net income –Quarter to 30 Jun 2022: revenue $50.5M, net income -$1.4MQuarter to 30 Jun 2022: revenue $50.5M, net income -$1.4MQuarter to 30 Sep 2022: revenue $58.7M, net income $1.3MQuarter to 30 Sep 2022: revenue $58.7M, net income $1.3MQuarter to 31 Dec 2022: revenue $54.3M, net income $451KQuarter to 31 Dec 2022: revenue $54.3M, net income $451KQuarter to 31 Mar 2023: revenue $55.6M, net income $611KQuarter to 31 Mar 2023: revenue $55.6M, net income $611KQuarter to 30 Jun 2023: revenue $50.6M, net income -$549KQuarter to 30 Jun 2023: revenue $50.6M, net income -$549KQuarter to 30 Sep 2023: revenue $53.2M, net income -$1.2MQuarter to 30 Sep 2023: revenue $53.2M, net income -$1.2MQuarter to 31 Dec 2023: revenue $53.5M, net income $2.1MQuarter to 31 Dec 2023: revenue $53.5M, net income $2.1MQuarter to 31 Mar 2024: revenue $58.9M, net income -$254.6MQuarter to 31 Mar 2024: revenue $58.9M, net income -$254.6MQuarter to 30 Jun 2024: revenue $58.2M, net income $3.4MQuarter to 30 Jun 2024: revenue $58.2M, net income $3.4MQuarter to 30 Sep 2024: revenue $57.8M, net income $3.4MQuarter to 30 Sep 2024: revenue $57.8M, net income $3.4MQuarter to 31 Dec 2024: revenue $62.8M, net income -$1.7MQuarter to 31 Dec 2024: revenue $62.8M, net income -$1.7MQuarter to 31 Mar 2025: revenue $62.1M, net income -$7.1MQuarter to 31 Mar 2025: revenue $62.1M, net income -$7.1MQuarter to 30 Jun 2025: revenue $59.5M, net income $4.7MQuarter to 30 Jun 2025: revenue $59.5M, net income $4.7MQuarter to 30 Sep 2025: revenue $60.7M, net income $2.5MQuarter to 30 Sep 2025: revenue $60.7M, net income $2.5MQuarter to 31 Dec 2025: revenue $65.1M, net income $3.6MQuarter to 31 Dec 2025: revenue $65.1M, net income $3.6MQuarter to 31 Mar 2026: revenue $63.7M, net income -$4.1MQuarter to 31 Mar 2026: revenue $63.7M, net income -$4.1MQuarter to 30 Jun 2026: revenue $60.1M, net income $2.8MQuarter to 30 Jun 2026: revenue $60.1M, net income $2.8MQuarter to 30 Sep 2026: revenue $62.3M, net income $4.3MQuarter to 30 Sep 2026: revenue $62.3M, net income $4.3M
31 Dec 2021RevenueNet incomeNet losstallest bar $254.6M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$62.3M$4.3M
30 Jun 2026$60.1M$2.8M
31 Mar 2026$63.7M-$4.1M
31 Dec 2025$65.1M$3.6M
30 Sep 2025$60.7M$2.5M
30 Jun 2025$59.5M$4.7M
31 Mar 2025$62.1M-$7.1M
31 Dec 2024$62.8M-$1.7M
30 Sep 2024$57.8M$3.4M
30 Jun 2024$58.2M$3.4M
31 Mar 2024$58.9M-$254.6M
31 Dec 2023$53.5M$2.1M
30 Sep 2023$53.2M-$1.2M
30 Jun 2023$50.6M-$549K
31 Mar 2023$55.6M$611K
31 Dec 2022$54.3M$451K
30 Sep 2022$58.7M$1.3M
30 Jun 2022$50.5M-$1.4M
31 Mar 2022$58.9M–
31 Dec 2021$54.7M-$2.1M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $251.3M $245.3M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +2.5% +10%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $6.7M -$1.6M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $1.15 -$0.31
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 64.8% 62.2% 55.1%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 10.4% 6.1% 15.1%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 2.7% -0.6% 9.5%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 3.6% 8.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $49.5M –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $22.3M $20.4M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.58
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $34.62
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 108 30.9
P/SPrice to sales: market cap divided by revenue of the last 12 months. 2.9 3.1
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 6.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.7 3.2
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 0.50% 0.50%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Mesa LaboratoriesMLAB (this company) $719.0M1082.9+2.5%2.7%
SenseonicsSENS $439.3Mloss7.3+105%-204%
Hurco CosHURC $121.9Mloss0.67-1.9%-3.6%
Sensata TechnologiesST $5.2B14.11.3+4.1%9.5%
RalliantRAL $7.0Bloss3.1+10%-52.1%
CognexCGNX $7.5B30.96.6+16%21.5%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+15%

180 13F filers vs 156

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

98%

5.5M shares held by 13F filers (30 Sep 2026) of 5.6M outstanding (2 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

6.7%

377K shares sold short (30 Oct 2026) of 5.6M outstanding (2 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.7

377K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-3.4%

391K shares sold short in the report before, 377K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

70%

70% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 57%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+2.6%

$62.3M vs $60.7M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-65%

$387K vs $1.1M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$580K

the 12 months before: $545K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

5

5 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

5 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Unusual now sharp changes in the last 90 days, compared with its own past

  • New institutional positions 42, 1.9× a year earlier

Price $127.93 on 20 Nov 2026, +79% over 12 months (12-month range $70.60 to $142.23)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $216K in the last 12 months (the 12 months before: -$2.9M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $62.3M in the latest quarter, +2.6% on a year earlier.
Capital spending per quarter. Capital spending $387K in the latest quarter, -65% on a year earlier.
Institutional holders (13F filers). 180 13F filers reported holding it in the latest 13F quarter, +34% on a year earlier.
Federal obligations. Federal obligations: $289K published in the last 12 months, -57% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 2026Sharp changeMany funds opening a new position: many funds opening a new position, 42 vs usual 18.50 (2026-09-30); 1.9x the same period a year earlier
13 Oct 20268-K and other filingsRestructuring costs announced
15 Jun 20268-K and other filingsDirector or officer change
23 Mar 20268-K and other filingsDirector or officer change
11 Mar 2026Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 452K)
9 Mar 20268-K and other filingsDirector or officer change
9 Mar 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Jun 20258-K and other filingsChanged its auditor
10 Sep 20248-K and other filingsChanged its auditor
14 Jun 20248-K and other filingsReport will be filed late
2 Apr 20248-K and other filingsAsset write-down (impairment)
8 Jan 20248-K and other filingsDirector or officer change
8 Jan 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Aug 20238-K and other filingsChanged its auditor
8 May 20238-K and other filingsDirector or officer change
8 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Nov 2022Sharp changeQuarterly revenue change: quarterly revenue change, 58.7M vs usual 36.9M (2022-09-30); 1.6x the same period a year earlier
9 Aug 2022Sharp changeQuarterly revenue change: quarterly revenue change, 50.5M vs usual 35.4M (2022-06-30); 1.4x the same period a year earlier
27 Jun 20228-K and other filingsDirector or officer change
7 Jun 2022Sharp changeQuarterly revenue change: quarterly revenue change, 58.9M vs usual 34.6M (2022-03-31); 1.6x the same period a year earlier
8 Apr 20228-K and other filingsDirector or officer change
8 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Feb 2022Sharp changeQuarterly revenue change: quarterly revenue change, 54.7M vs usual 34.2M (2021-12-31); 1.6x the same period a year earlier
Insider net buying (open market)
Month from 1 Dec 2021: -$1.8M published
Month from 1 Jan 2022: -$328K published
Month from 1 Feb 2022: -$1.3M published
Month from 1 Mar 2022: -$402K published
Month from 1 Apr 2022: -$18K published
Month from 1 Jun 2022: -$1.7M published
Month from 1 Aug 2022: -$1.0M published
Month from 1 Nov 2022: -$439K published
Month from 1 Dec 2022: -$40K published
Month from 1 Jan 2023: -$742K published
Month from 1 Feb 2023: -$184K published
Month from 1 Mar 2023: -$1.0M published
Month from 1 Sep 2023: -$1.1M published
Month from 1 Dec 2023: -$169K published
Month from 1 Sep 2024: -$187K published
Month from 1 Oct 2024: -$572K published
Month from 1 Mar 2025: -$2.6M published
Month from 1 Jun 2025: -$297K published
Month from 1 Mar 2026: $452K published
Month from 1 Jun 2026: -$770K published
Month from 1 Aug 2026: $102K published
H-1B/E-3 applications certified
Quarter from 1 Jul 2023: 1 published
Quarter from 1 Apr 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $54.7M, +60% on a year earlier; public on 4 Feb 2022
Quarter ended 31 Mar 2022: $58.9M, +55% on a year earlier; public on 1 Jun 2022
Quarter ended 30 Jun 2022: $50.5M, +44% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $58.7M, +64% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $54.3M, -0.7% on a year earlier; public on 7 Feb 2023
Quarter ended 31 Mar 2023: $55.6M, -5.6% on a year earlier; public on 31 May 2023
Quarter ended 30 Jun 2023: $50.6M, +0.4% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $53.2M, -9.5% on a year earlier; public on 7 Nov 2023
Quarter ended 31 Dec 2023: $53.5M, -1.5% on a year earlier; public on 6 Feb 2024
Quarter ended 31 Mar 2024: $58.9M, +6.0% on a year earlier; public on 29 Jun 2024
Quarter ended 30 Jun 2024: $58.2M, +15% on a year earlier; public on 6 Aug 2024
Quarter ended 30 Sep 2024: $57.8M, +8.8% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $62.8M, +18% on a year earlier; public on 5 Feb 2025
Quarter ended 31 Mar 2025: $62.1M, +5.5% on a year earlier; public on 29 May 2025
Quarter ended 30 Jun 2025: $59.5M, +2.4% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $60.7M, +5.0% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $65.1M, +3.6% on a year earlier; public on 4 Feb 2026
Quarter ended 31 Mar 2026: $63.7M, +2.6% on a year earlier; public on 4 Jun 2026
Quarter ended 30 Jun 2026: $60.1M, +1.0% on a year earlier; public on 11 Aug 2026
Quarter ended 30 Sep 2026: $62.3M, +2.6% on a year earlier; public on 10 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $2.1M, +734% on a year earlier; public on 4 Feb 2022
Quarter ended 31 Mar 2022: $782K, -25% on a year earlier; public on 1 Jun 2022
Quarter ended 30 Jun 2022: $225K, -66% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $1.6M, +75% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $1.7M, -20% on a year earlier; public on 7 Feb 2023
Quarter ended 31 Mar 2023: $1.0M, +31% on a year earlier; public on 31 May 2023
Quarter ended 30 Jun 2023: $270K, +20% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $634K, -61% on a year earlier; public on 7 Nov 2023
Quarter ended 31 Dec 2023: $1.1M, -32% on a year earlier; public on 6 Feb 2024
Quarter ended 31 Mar 2024: $535K, -48% on a year earlier; public on 29 Jun 2024
Quarter ended 30 Jun 2024: $891K, +230% on a year earlier; public on 6 Aug 2024
Quarter ended 30 Sep 2024: $1.8M, +182% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $813K, -28% on a year earlier; public on 5 Feb 2025
Quarter ended 31 Mar 2025: $757K, +41% on a year earlier; public on 29 May 2025
Quarter ended 30 Jun 2025: $1.0M, +13% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $1.1M, -39% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $732K, -10% on a year earlier; public on 4 Feb 2026
Quarter ended 31 Mar 2026: $417K, -45% on a year earlier; public on 4 Jun 2026
Quarter ended 30 Jun 2026: $559K, -45% on a year earlier; public on 11 Aug 2026
Quarter ended 30 Sep 2026: $387K, -65% on a year earlier; public on 10 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 159; public on 14 Feb 2022
31 Mar 2022 report: 165; public on 16 May 2022
30 Jun 2022 report: 162; public on 15 Aug 2022
30 Sep 2022 report: 143; public on 14 Nov 2022
31 Dec 2022 report: 143; public on 14 Feb 2023
31 Mar 2023 report: 151; public on 15 May 2023
30 Jun 2023 report: 150; public on 14 Aug 2023
30 Sep 2023 report: 140; public on 14 Nov 2023
31 Dec 2023 report: 146; public on 14 Feb 2024
31 Mar 2024 report: 151; public on 15 May 2024
30 Jun 2024 report: 147; public on 14 Aug 2024
30 Sep 2024 report: 160; public on 14 Nov 2024
31 Dec 2024 report: 156; public on 14 Feb 2025
31 Mar 2025 report: 150; public on 15 May 2025
30 Jun 2025 report: 146; public on 14 Aug 2025
30 Sep 2025 report: 134; public on 14 Nov 2025
31 Dec 2025 report: 155; public on 17 Feb 2026
31 Mar 2026 report: 154; public on 15 May 2026
30 Jun 2026 report: 156; public on 14 Aug 2026
30 Sep 2026 report: 180; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $37K published
Month from 1 Dec 2021: $53K published
Month from 1 Jan 2022: $112K published
Month from 1 Feb 2022: $40K published
Month from 1 Mar 2022: $25K published
Month from 1 Apr 2022: $16K published
Month from 1 May 2022: $11K published
Month from 1 Jun 2022: $7K published
Month from 1 Jul 2022: $31K published
Month from 1 Aug 2022: $102K published
Month from 1 Sep 2022: $236K published
Month from 1 Oct 2022: $19K published
Month from 1 Nov 2022: $97K published
Month from 1 Dec 2022: $0 published
Month from 1 Jan 2023: $41K published
Month from 1 Feb 2023: $46K published
Month from 1 Mar 2023: $94K published
Month from 1 Apr 2023: $36K published
Month from 1 May 2023: $13K published
Month from 1 Jun 2023: $52K published
Month from 1 Jul 2023: $56K published
Month from 1 Aug 2023: $195K published
Month from 1 Sep 2023: $26K published
Month from 1 Nov 2023: $9K published
Month from 1 Jan 2024: $61K published
Month from 1 Mar 2024: -$38K published
Month from 1 Apr 2024: $32K published
Month from 1 May 2024: $20K published
Month from 1 Jun 2024: -$13K published
Month from 1 Jul 2024: $50K published
Month from 1 Aug 2024: $242K published
Month from 1 Sep 2024: $42K published
Month from 1 Oct 2024: $9K published
Month from 1 Dec 2024: $12K published
Month from 1 Jan 2025: $135K published
Month from 1 May 2025: $43K published
Month from 1 Jul 2025: $44K published
Month from 1 Aug 2025: $45K published
Month from 1 Sep 2025: $202K published
Month from 1 Oct 2025: $173K published
Month from 1 Nov 2025: $12K published
Month from 1 Jan 2026: $8K published
Month from 1 Feb 2026: $7K published
Month from 1 Mar 2026: $77K published
Month from 1 Apr 2026: $18K published
Month from 1 May 2026: $50K published
Month from 1 Jun 2026: -$22K published
Month from 1 Jul 2026: $20K published
Month from 1 Aug 2026: $127K published
Month from 1 Sep 2026: $4K published
Month from 1 Oct 2026: $0 published

What is unusual now

  • Made public in the last 90 days: it saw 42 13F filers open a new position in the quarter ended 30 Sep 2026, 1.9× the same quarter last year.
  • Many funds opening a new position: saw 42 13F filers open a new position in the quarter ended 30 Sep 2026, 1.9× the same quarter last year Public on 16 Nov 2026.
  • Insider net buying (open market): Insiders sold a net $216K in the last 12 months (the 12 months before: -$2.9M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).

Latest records

The names and amounts behind the totals, newest first

No trades in the last 90 days; the latest was filed 17 Aug 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
17 Aug 2026Siddhartha KadiaPresident and CEOBuy7,093$112.80$800KForm 4
17 Aug 2026R Tony TripenyDirectorBuy900$113.69$102KForm 4
17 Aug 2026John James SullivanDirectorSell7,093$112.80$800KForm 4
23 Jun 2026John SakysCFOSellafter exercising options2,827$89.50$253KForm 4
23 Jun 2026Lyndsey Elizabeth CrennenCAOSellafter exercising options442$89.50$40KForm 4
23 Jun 2026Brian David ArchboldSVP OperationsSellafter exercising options2,516$89.50$225KForm 4
17 Jun 2026John SakysCFOSellplanned in advance (10b5-1)1,223$101.27$124KForm 4
17 Jun 2026Lyndsey Elizabeth CrennenCAOSellplanned in advance (10b5-1)118$101.27$12KForm 4

180 institutions reported shares at the end of Q3 2026, 98% of the shares outstanding; 42 opened a position, 18 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Long Path Partners LP480K8.54%$62.4M+3,043+0.6%
BlackRock, Inc.458K8.14%$59.5M+17K+3.9%
Wasatch Advisors LP387K6.89%$50.3M+271K+235%
Victory Capital Management Inc277K4.92%$35.9MNew+277K
Vanguard Capital Management LLC236K4.20%$30.7M-1,243-0.5%
Raymond James Financial Inc175K3.11%$22.7M+25K+17%
Arrowstreet Capital, Limited Partnership173K3.08%$22.5MNew+173K
Geode Capital Management, LLC166K2.95%$21.5M+26K+19%
Dimensional Fund Advisors LP164K2.92%$21.3M+16K+10%
Jacobs Levy Equity Management, Inc146K2.59%$18.9M+15K+11%

Company events

All 40 company events

In 12 months: 3 director or officer changes, 1 restructuring. Results releases and routine reports are left out.

FiledWhat happenedSource
13 Oct 2026Restructuring costs announced8-K
15 Jun 2026Director or officer change8-K
23 Mar 2026Director or officer change8-K
9 Mar 2026Director or officer change8-K
6 Jun 2025Changed its auditor8-K
10 Sep 2024Changed its auditor8-K
14 Jun 2024Annual report will be filed lateNT 10-K
8 Apr 2024Signed a major agreement8-K

The 5 newest of 33 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 16 Nov 2026Institutional holdings change

    saw 42 13F filers open a new position in the quarter ended 30 Sep 2026, 1.9× the same quarter last year.

    Same quarter last year: 22; its normal quarter is 18.5.

    See the evidence
    This period
    42 (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    18.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +6.3
    Same quarter last year
    22
    History used
    4,748 days
    2024-09-30: 262024-12-31: 92025-03-31: 182025-06-30: 192025-09-30: 222025-12-31: 312026-03-31: 172026-06-30: 182026-09-30: 42
    the quarter ended 30 Sep 20268 earlier quartersnormal: 18.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  2. 13 Oct 2026Filings record

    Restructuring costs announced

  3. 18 Aug 2026Insiders record

    Kadia Siddhartha (President and CEO) bought 7,093 shares of MLAB ($800,090) (dated 17 Aug 2026)

  4. 18 Aug 2026Insiders record

    Tripeny R Tony (director) bought 900 shares of MLAB ($102,321) (dated 17 Aug 2026)

  5. 15 Jun 2026Filings record

    Director or officer change

  6. 23 Mar 2026Filings record

    Director or officer change

  7. 11 Mar 2026Insiders change

    had 3 insiders buy $452K of its shares on the open market within 30 days (3 filings).

    Who bought: Ladiwala Shiraz Shabanali, Tripeny R Tony, Capone Mark Christopher.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $452K
    Window
    9 Feb 2026 to 11 Mar 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  8. 11 Mar 2026Insiders record

    Capone Mark Christopher (director) bought 1,301 shares of MLAB ($99,331) (dated 10 Mar 2026)

  9. 11 Mar 2026Insiders record

    Tripeny R Tony (director) bought 1,315 shares of MLAB ($99,940) (dated 10 Mar 2026)

  10. 11 Mar 2026Insiders record

    Ladiwala Shiraz Shabanali (director) bought 3,500 shares of MLAB ($252,805) (dated 10 Mar 2026)

  11. 9 Mar 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 9 Mar 2026Filings record

    Director or officer change

  13. 6 Jun 2025Filings record

    Changed its auditor

  14. 10 Sep 2024Filings record

    Changed its auditor

  15. 14 Jun 2024Filings record

    Report will be filed late

  16. 2 Apr 2024Filings record

    Asset write-down (impairment)

  17. 8 Jan 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 8 Jan 2024Filings record

    Director or officer change

  19. 30 Aug 2023Filings record

    Changed its auditor

  20. 8 May 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  21. 8 May 2023Filings record

    Director or officer change

  22. 8 Nov 2022Financials change

    reported revenue of $58.7M for the quarter ended 30 Sep 2022, 1.6× the same quarter last year.

    Same quarter last year: $35.8M; its normal quarter is $36.9M.

    See the evidence
    This period
    $58.7M (the quarter ended 30 Sep 2022)
    Normal quarter (median of 8 earlier)
    $36.9M
    Typical spread (median absolute deviation)
    $3.9M
    How far from its usual level
    +3.8
    Same quarter last year
    $35.8M
    History used
    4,475 days
    2020-09-30: $31.9M2020-12-31: $34.2M2021-03-31: $38.0M2021-06-30: $34.9M2021-09-30: $35.8M2021-12-31: $54.7M2022-03-31: $58.9M2022-06-30: $50.5M2022-09-30: $58.7M
    the quarter ended 30 Sep 20228 earlier quartersnormal: $36.9M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  23. 10 Aug 2022Insiders record

    Tripeny R Tony (director) bought 500 shares of MLAB ($100,000) (dated 9 Aug 2022)

  24. 9 Aug 2022Financials change

    reported revenue of $50.5M for the quarter ended 30 Jun 2022, 1.4× the same quarter last year.

    Same quarter last year: $34.9M; its normal quarter is $35.4M.

    See the evidence
    This period
    $50.5M (the quarter ended 30 Jun 2022)
    Normal quarter (median of 8 earlier)
    $35.4M
    Typical spread (median absolute deviation)
    $3.1M
    How far from its usual level
    +3.3
    Same quarter last year
    $34.9M
    History used
    4,383 days
    2020-06-30: $29.9M2020-09-30: $31.9M2020-12-31: $34.2M2021-03-31: $38.0M2021-06-30: $34.9M2021-09-30: $35.8M2021-12-31: $54.7M2022-03-31: $58.9M2022-06-30: $50.5M
    the quarter ended 30 Jun 20228 earlier quartersnormal: $35.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  25. 27 Jun 2022Filings record

    Director or officer change

  26. 7 Jun 2022Financials change

    reported revenue of $58.9M for the quarter ended 31 Mar 2022, 1.6× the same quarter last year.

    Same quarter last year: $38.0M; its normal quarter is $34.6M.

    See the evidence
    This period
    $58.9M (the quarter ended 31 Mar 2022)
    Normal quarter (median of 8 earlier)
    $34.6M
    Typical spread (median absolute deviation)
    $2.0M
    How far from its usual level
    +7.0
    Same quarter last year
    $38.0M
    History used
    4,292 days
    2020-03-31: $34.2M2020-06-30: $29.9M2020-09-30: $31.9M2020-12-31: $34.2M2021-03-31: $38.0M2021-06-30: $34.9M2021-09-30: $35.8M2021-12-31: $54.7M2022-03-31: $58.9M
    the quarter ended 31 Mar 20228 earlier quartersnormal: $34.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  27. 8 Apr 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 8 Apr 2022Filings record

    Director or officer change

  29. 8 Feb 2022Financials change

    reported revenue of $54.7M for the quarter ended 31 Dec 2021, 1.6× the same quarter last year.

    Same quarter last year: $34.2M; its normal quarter is $34.2M.

    See the evidence
    This period
    $54.7M (the quarter ended 31 Dec 2021)
    Normal quarter (median of 8 earlier)
    $34.2M
    Typical spread (median absolute deviation)
    $2.0M
    How far from its usual level
    +6.0
    Same quarter last year
    $34.2M
    History used
    4,202 days
    2019-12-31: $31.7M2020-03-31: $34.2M2020-06-30: $29.9M2020-09-30: $31.9M2020-12-31: $34.2M2021-03-31: $38.0M2021-06-30: $34.9M2021-09-30: $35.8M2021-12-31: $54.7M
    the quarter ended 31 Dec 20218 earlier quartersnormal: $34.2M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  30. 29 Oct 2021Filings record

    Director or officer change

  31. 21 Oct 2021Filings record

    Completed an acquisition or asset sale

  32. 29 Sep 2021Filings record

    Director or officer change

  33. 3 Sep 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 3 Sep 2021Filings record

    Director or officer change

  35. 1 Oct 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 1 Oct 2020Filings record

    Director or officer change

  37. 15 May 2020Filings record

    Director or officer change

  38. 2 Apr 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 2 Apr 2020Filings record

    Director or officer change

  40. 1 Nov 2019Filings record

    Completed an acquisition or asset sale

Showing the newest 40 of 55 entries; narrow the window or the kind of data to see older ones.

Not listed: 289 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000724004
Ticker
MLAB
Domain
mesalabs.com
Employer name
Mesa Laboratories, Inc. (1 unverified)
Hq location
CO|LAKEWOOD|80228 (1 unverified)
Name
Agena Bioscience China, Agena Bioscience GmbH, Agena Bioscience HK, Beijing GKE Science & Technology Co. Ltd and 12 more
Uei
N36KBDHE4D23
  • DOL H-1B labor condition applications and PERM certifications10 data points19 Jun 2023 to 23 Feb 2026
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)153 records4 Jan 2016 to 9 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1162 data points31 Mar 2010 to 2 Nov 2026
  • SEC Form 4 insider transactions174 records, 540 data points25 Feb 2016 to 17 Aug 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards2094 data points1 Oct 2007 to 8 Sep 2026